← Evidence map

ArticleGastroenterology & hepatology2023

Safety and Efficacy of Risankizumab in Crohn's Disease: Prospective Real-World Experience and Systematic Literature Review.

PubMed ↗Full text ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38444456